Insight into Elderly ALS Patients in the Emilia Romagna Region: Epidemiological and Clinical Features of Late-Onset ALS in a Prospective, Population-Based Study
Authors:
- Giulia GianferrariGiulia Gianferrari
- Ilaria MartinelliIlaria Martinelli
- Cecilia SimoniniCecilia Simonini
- Elisabetta ZucchiEZElisabetta Zucchi
- Nicola FiniNFNicola Fini
- Maria CaputoMCMaria Caputo
- Andrea GhezziAGAndrea Ghezzi
- Annalisa GessaniAGAnnalisa Gessani
- Elena CanaliECElena Canali
- Mario CasmiroMCMario Casmiro
- Patrizia De MassisPMPatrizia De Massis
- Marco Curro’ DossiMDMarco Curro’ Dossi
Open Access
Abstract
Few studies have focused on elderly (>80 years) amyotrophic lateral sclerosis (ALS) patients, who represent a fragile subgroup generally not included in clinical trials and often neglected because they are more difficult to diagnose and manage. We analyzed the clinical and genetic features of very late-onset ALS patients through a prospective, population-based study in the Emilia Romagna Region of Italy. From 2009 to 2019, 222 (13.76%) out of 1613 patients in incident cases were over 80 years old at diagnosis, with a female predominance (F:M = 1.18). Elderly ALS patients represented 12.02% of patients before 2015 and 15.91% from 2015 onwards (p = 0.024). This group presented with bulbar onset in 38.29% of cases and had worse clinical conditions at diagnosis compared to younger patients, with a lower average BMI (23.12 vs. 24.57 Kg/m2), a higher progression rate (1.43 vs. 0.95 points/month), and a shorter length of survival (a median of 20.77 vs. 36 months). For this subgroup, genetic analyses have seldom been carried out (25% vs. 39.11%) and are generally negative. Finally, elderly patients underwent less frequent nutritional- and respiratory-supporting procedures, and multidisciplinary teams were less involved at follow-up, except for specialist palliative care. The genotypic and phenotypic features of elderly ALS patients could help identify the different environmental and genetic risk factors that determine the age at which disease onset occurs. Since multidisciplinary management can improve a patient’s prognosis, it should be more extensively applied to this fragile group of patients.Keywords
Funding Information
- The Emilia Romagna Regional Health Authority (GPG/2022/1343)
This publication has 50 references indexed in Scilit:
- Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genesJournal of Medical Genetics, 2012
- ALS clinical trialsNeurology, 2011
- EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task forceEuropean Journal of Neurology, 2011
- Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutationActa Neuropathologica, 2011
- Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based studyJournal of Neurology, Neurosurgery & Psychiatry, 2011
- Older Patients in the Emergency Department: A ReviewAnnals of Emergency Medicine, 2010
- ALSFRS-R score and its ratio: A useful predictor for ALS-progressionJournal of the Neurological Sciences, 2008
- Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALSNeurology, 2006
- The ALSFRSr predicts survival time in an ALS clinic populationNeurology, 2005
- The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or overAge and Ageing, 2004